Inbone buy to grow Wright's offerings
This article was originally published in Clinica
Arlington, Tennesse-based orthopaedic company Wright Medical has agreed to acquire privately-held foot and ankle implant manufacturer Inbone Technologies for $24m in cash. The deal also includes additional payments, which includes a guaranteed minimum of $3.7m, based on Inbone's future financial performance. Wright said it will begin US distribution of Inbone's products immediately on completion of the transaction. Inbone has developed a total ankle replacement system and an intra-osseous fusion rod and plate system for foot fusion.
You may also be interested in...
La Jolla’s formulation appears blocked by Amivas’ seven-year orphan exclusivity, and the company also will miss out on chance for a tropical disease priority review voucher; Amivas worked with the US Army to bring the severe malaria treatment through final stages of development and regulatory review.
The repurposed drug showed substantial improvement over existing therapies in second-line treatment of patients with HRAS-mutant tumors.
With an eye toward addressing uncertainty as to whether patents that cover drug products’ device components or risk management elements should be listed, the agency seeks input on the need for additional clarity around the types of patents that must be submitted and the impact of any change in listing practices on drug development.